NAC endorsements

Endorsements

The NAC will consider endorsement of published evidence‐based guidelines that meet its mandate and principles pertaining to blood medicine practice and based on a systematic review of the literature. Criteria for guidelines to have endorsement by NAC are adapted from the 2013 National Guideline Clearinghouse Inclusion criteria. If you wish to submit a clinical practice guideline for potential endorsement by NAC, please review the NAC Framework for Guideline Endorsement.

NAC Framework for Guideline Endorsement

NAC Endorsement with Caveats: International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn

NAC Endorsement with Caveats: Red Blood Cell Transfusion: 2023 AABB International Guidelines

NAC Endorsement: ICTMG Guidelines on Platelet Transfusion for Patients with Hypoproliferative Thrombocytopenia

NAC Endorsement: ICTMG Guidelines on RBC Specifications for Patients with Hemoglobinopathies

NAC Endorsement: Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically III Children: From the Transfusion and Anemia Expertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB).

NAC Endorsement: ICTMG Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) Guidelines

NAC Endorsement: The European Guideline on Management of Major Bleeding and Coagulopathy Following Trauma: Fifth Edition (joint endorsement with the Trauma Association of Canada)